COMP <GO>
WVE vs SGMT // REVENUE GROWTH (YOY)
Wave Life Sciences Inc. (NASDAQ) VS. Sagimet Biosciences Inc. (Series A) (NASDAQ) • 15-METRIC TALLY: WVE 0
— SGMT 2
■ METRIC PARITY
LAST: $3.63 (-0.28%) • MKT CAP: $715.9M
revenue-growth
-60.50%
LAST: $10.43 (-2.89%) • MKT CAP: $735.7M
revenue-growth
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (WVE VS. SGMT)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | WVE | SGMT | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | -6.21% | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | -60.00% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | -60.50% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.85 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 2/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 49.1 | 53.2 | -4.09 | SGMT | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $715.9M | $735.7M | -$19.7M | SGMT | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | WVE REV | SGMT REV | WVE GROSS % | SGMT GROSS % | WVE FCF | SGMT FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $42.7M | $0 | — | — | -$188.2M | -$45.6M |
| FY 2024 | $108.3M | $0 | — | — | -$152.0M | -$42.4M |
| FY 2023 | $113.3M | $2.0M | — | — | -$19.4M | -$23.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
WVE // BETA —
SGMT // BETA —